Immunotherapy response in patients with cutaneous squamous cell carcinoma of head and neck with cranial nerve involvement
Head & Neck · 2023-08 · 45 (8) · 2149-2154
DOI: 10.1002/hed.27419 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, online erschienen am 05.06.2023. Verfasst von Nerea Lopetegui-Lia und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology/Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Skin Neoplasms, Head and Neck Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Metastatic or locally advanced cutaneous squamous cell carcinoma (cSCC) can be treated with immunotherapy (IO). Cranial nerve involvement (CNI) is uncommon in cSCC and is a poor prognostic factor. Our aim is to describe how patients with CNI respond to IO monotherapy and/or as an adjunct to RT.
Methods
Under an IRB approved protocol, patients with histologically proven cSCC of the head and neck with CNI treated with IO were retrospectively reviewed.
Results
Twelve patients were included and received cemiplimab or pembrolizumab. Eight patients had CNI at diagnosis, and 4 at time of recurrence after non‐IO therapy. Best responses were complete response (1), partial response (7), stable disease (1), progressive disease (2), and pending response (1). Nine patients are alive, 6 of which remain on IO.
Conclusions
In this cohort, IO showed clinical response in 83% of patients, indicating IO can be an effective monotherapy, reserving RT for instances of local failure after IO.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hematology/Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.
- Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.
- Department of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
- Department of Otolaryngology, Head and Neck Institute, Cleveland Clinic, Cleveland, Ohio, USA.
ORCID-Profile: Nerea Lopetegui-Lia, Anirudh Yalamanchali, Eric Lamarre, Neil McIver Woody, Emrullah Yilmaz
Zitieren
APA
Lopetegui-Lia, N., Dima, D., Buchberger, D. S., Yalamanchali, A., Osantowski, B., Ondeck, M., Lorenz, R. R., Prendes, B., Ku, J., Lamarre, E., Scharpf, J., Silver, N. L., Schwartzman, L., Geiger, J. L., Woody, N. M., Campbell, S. R., Koyfman, S. A., & Yilmaz, E. (2023). Immunotherapy response in patients with cutaneous squamous cell carcinoma of head and neck with cranial nerve involvement. Head & Neck, 45(8), 2149-2154. https://doi.org/10.1002/hed.27419
Vancouver
Lopetegui-Lia N, Dima D, Buchberger DS, Yalamanchali A, Osantowski B, Ondeck M, et al. Immunotherapy response in patients with cutaneous squamous cell carcinoma of head and neck with cranial nerve involvement. Head & Neck. 2023;45(8):2149-2154. doi:10.1002/hed.27419
BibTeX
@article{LopeteguiLia2023,
author = {Lopetegui-Lia, Nerea and Dima, Danai and Buchberger, David Scott and Yalamanchali, Anirudh and Osantowski, Bennett and Ondeck, Mariah and Lorenz, Robert Roman and Prendes, Brandon and Ku, Jamie and Lamarre, Eric and Scharpf, Joseph and Silver, Natalie Lea and Schwartzman, Larisa and Geiger, Jessica Lyn and Woody, Neil McIver and Campbell, Shauna Rosalie and Koyfman, Shlomo A and Yilmaz, Emrullah},
title = {Immunotherapy response in patients with cutaneous squamous cell carcinoma of head and neck with cranial nerve involvement},
journal = {Head & Neck},
year = {2023},
volume = {45},
number = {8},
pages = {2149--2154},
doi = {10.1002/hed.27419}
}
EUVIMED